arrow
Back
S

Sara M. Tolaney

harvard medical school

83H-index
1.3KPaper Count
3.6WCitation Count
Published Papers 390
Publication Date
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
err2026-07-30
err0
PREAI
errSolange Peters; Petros Grivas; Christophe Massard; Sara M. Tolaney; Michel Obeid
errShare
errSave
Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study
err2026-07-24
err0
errOAAI
errH.S. Rugo; K. Jhaveri; S. Pernas; B. Pistilli; S.-A. Im; M. De Laurentiis; S. Wang; N. Martínez Jañez; G. Borges; D.W. Cescon; M. Hattori; Y.-S. Lu; E. Hamilton; Q. Zhang; J. Tsurutani; K. Kalinsky; P.E. Rubini Liedke; Z. Nowecki; S.M. Tolaney; K. Zhao
errShare
errSave
Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer☆
err2026-06-08
err0
errOAAI
errE. Salehi; X. Chu; E.L. Mayer; S. Singer; G. Augdahl; M. Stalteri; T. Li; K.E. Dibble; N. Sinclair; M. Faggen; J. Walsh; S. Sammons; K. Sendrick; S. Hanna; A. Mostaghimi; N. Tayob; N.R. LeBoeuf; S.M. Tolaney
errShare
errSave
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
err2026-05-16
err0
errOAAI
errAna C. Garrido-Castro; Noah Graham; Katelyn X. Li; Lynn Bi; Jett Crowdis; Kevin Bi; Jihye Park; Ricardo Pastorello; Yvonne Li; Hersh Gupta; Thomas Kuntz; Russell Petry; Lincoln W. Pasquina; Ashka Patel; Paulina Lange; Molly DiLullo; Victoria Attaya; Anna Mae Frey; Merrida A. Childress; Robert Wesolowski; Natalie Sinclair; Sarah Sinclair; Steve Lo; Nadine Tung; Meredith Faggen; Peter A. Kaufman; Caroline C. Block; Jeanna Walsh; Madhavi Toke; Wendy Chen; Kai W. Wucherpfennig; Ye Tian; Amy J. Williams; Satabhisa Mukhopadhyay; Tathagata Dasgupta; Stuart Schnitt; Andrew D. Cherniack; Romualdo Barroso; Jennifer Ligibel; Nancy U. Lin; Elizabeth A. Mittendorf; Nabihah Tayob; Eliezer Van Allen; Sara M. Tolaney
errShare
errSave
Clinically Meaningful, Patient-Centered Endpoints for Real-World Evidence Generation in Breast Cancer: Perspectives from the Multidisciplinary TRIUMPH Initiative
err2026-03-17
err0
errOAAI
errSean Khozin; Nancy A. Dreyer; Dominic Galante; Raymond Liu; Peter Neumann; Nathan Nussbaum; Joyce O’Shaughnessy; Mothaffar F. Rimawi; Hope S. Rugo; Sara M. Tolaney; Marisa Weiss; Adam Brufsky
errShare
errSave
Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials
err2026-03-05
err0
errOAAI
errK. Jhaveri; F.C. Bidard; K. Kalinsky; P. Neven; H.S. Rugo; S.M. Tolaney; L.M. Litchfield; C.C. von Laue; S. Traore; F. Sapunar; Y. Li; J. O’Shaughnessy
errShare
errSave
Genomic landscape, immune microenvironment and survival in male versus female breast cancer☆
err2026-03-04
err0
errOAAI
errD. Trapani; S.K. Deshmukh; T. Samec; S. Wu; J. Xiu; P. Walker; D.L. Abravanel; P. Advani; P.M. Spanheimer; N.U. Lin; G. Curigliano; S.L. Graff; M. Lustberg; G.W. Sledge; S.M. Tolaney; J.P. Leone
errShare
errSave
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)
err2026-02-27
err0
errOAAI
errSarah L. Sammons; Thomas M. Kuntz; Molly DiLullo; Xochitl C. Morgan; Alyssa Martin; Melissa E. Hughes; Tasnim Rahman; Romualdo Barroso-Sousa; Esther Ritah Ogayo; Julia Giordano; Sean Ryan; Adrienne G. Waks; Ilana Schlam; Jennifer Ligibel; Nancy U. Lin; Ana C. Garrido-Castro; Elizabeth A. Mittendorf; Sara M. Tolaney
errShare
errSave
Circulating tumor DNA in neoadjuvant endocrine therapy for early breast cancer
err2026-02-10
err0
errOAAI
errA. Grinshpun; D. Dustin; M. Cai; M. Hughes; M. DiLullo; M. Moore; D. Yardley; I.A. Mayer; W.F. Symmans; E.L. Mayer; E.P. Winer; N.U. Lin; S.M. Tolaney; O. Metzger; R. Jeselsohn
errShare
errSave
Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data
err2026-01-19
err0
errOAAI
errS.M. Tolaney; S. Sammons; A. Sandoval-Leon; J. Cortes; A.M. Liepa; B.R. Grimes; D. He; Z.L. Cui; J. Roose; W. Gathirua-Mwangi; K. Moreira; J. O’Shaughnessy; P. Neven; S.R.D. Johnston; H.S. Rugo
errShare
errSave
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer
err2025-11-28
err0
errOAAI
errJingxin Fu; Adrienne G. Waks; Erica Pimenta; Breanna Titchen; Kevin Bi; Sabrina Camp; Theodora Pappa; Tanya Keenan; Erin Shannon; Sébastien Vigneau; Meredith Bemus; Anwesha Nag; Aaron R. Thorner; Jihye Park; Molly DiLullo; Eileen Wrabel; Rinath Jeselsohn; Elizabeth A. Mittendorf; Daniel L. Abravanel; Sara M. Tolaney; Eliezer M. Van Allen
errShare
errSave
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial
err2025-11-28
err0
errOAAI
errAdrienne G. Waks; Jingxin Fu; Xiangying Chu; Busem Binboga Kurt; Tianyu Li; Thomas M. Kuntz; Yizhuo Shen; David Yang; Kevin Meli; Brendan Reardon; Jihye Park; Ann Partridge; Daniel Abravanel; Rinath Jeselsohn; Eileen Wrabel; Jillian Alberti; Molly DiLullo; Serenity Chen; Ayesha Mohammed-Abreu; Xiaopeng Sun; Justin M. Balko; Miranda Kleijn; William Audeh; Xochitl C. Morgan; Ian E. Krop; Nabihah Tayob; Eliezer M. Van Allen; Elizabeth A. Mittendorf; Sara M. Tolaney
errShare
errSave
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02
err2025-11-17
err0
errOAAI
errS.A. Hurvitz; S. Loi; J. O’Shaughnessy; A.F.C. Okines; S.M. Tolaney; J. Sohn; C. Saura; X. Zhu; D. Cameron; T. Bachelot; E. Hamilton; G. Curigliano; A.C. Wolff; N. Harbeck; N. Masuda; L. Vahdat; K. Zaman; F. Valdes-Albini; M. Block; T. Pluard
errShare
errSave
TRADE: A phase II trial to assess the tolerability of abemaciclib dose escalation in early-stage HR+/HER2- breast cancer
err2025-10-17
err0
errOAAI
errE.L. Mayer; D. Trapani; S.-E. Kim; M. Faggen; N. Sinclair; P. Sanz-Altamira; C. Battelli; S. Berwick; S. Lo; J. Acevedo; S. Sinclair; A. Malcolm; L. Varella; S. Sammons; S. Schumer; P.D. Poorvu; E. Wallace; E. Pasternak; N. Tayob; S.M. Tolaney
errShare
errSave
errShare
errSave
Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study
err2025-10-03
err0
errOAAI
errKristina Fanucci; Eren D. Yeh; Ruichao Shi; Lei Qin; Camden P. Bay; Molly DiLullo; Ashka Patel; McKenna Moore; Zachary T. Herbert; Beth T. Harrison; Faina Nakhlis; Jennifer Bellon; Laura Warren; Jennifer L. Guerriero; Sara M. Tolaney; Meredith Regan; Beth Overmoyer; Steven Van Laere; Filipa Lynce
errShare
errSave
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
err2025-10-02
err0
PREAI
errAlfred Zippelius; Sara M. Tolaney; Paolo Tarantino; Joseph P. Balthasar; Greg M. Thurber
errShare
errSave
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
err2025-10-01
err4
PREAI
errCortes, Javier; Punie, Kevin; Barrios, Carlos; Hurvitz, Sara A.; Schneeweiss, Andreas; Sohn, Joohyuk; Tokunaga, Eriko; Brufsky, Adam; Park, Yeon Hee; Xu, Binghe; Hegg, Roberto; Oliveira, Mafalda; Fabi, Alessandra; Vaksman, Natalya; Valdez, Theresa; Zhang, Xinrui; Lai, Catherine; Tolaney, Sara M.
errShare
errSave
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA
err2025-09-09
err0
errOAAI
errHeather A. Parsons; Conor Messer; Katheryn Santos; Jakob Weiss; David Merrell; Brian P. Danysh; Melissa E. Hughes; Gregory J. Kirkner; Ashka Patel; Julian Hess; Kerry Sendrick; Chip Stewart; Elizabeth Grant; Kristy Schlueter-Kuck; Albert Grinshpun; Nikhil Wagle; Jamunarani Veeraraghavan; Jose Pablo Leone; Rachel A. Freedman; Otto Metzger; Rachel Schiff; Eric P. Winer; Sara M. Tolaney; Mothaffar Rimawi; Ian E. Krop; Gad Getz; Nancy U. Lin
errShare
errSave
The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study
err2025-08-29
err0
errOAAI
errKristen D. Brantley; Gregory J. Kirkner; Melissa E. Hughes; Leticia Varella; Georgia Suggs; Olivia M. Cunningham; Sanjana Ravikumar; Craig Snow; Sara M. Tolaney; Sarah Sammons; Ann H. Partridge; Nancy U. Lin
errShare
errSave